Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $547.90 million. The enterprise value is $455.33 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 126.83 million shares outstanding. The number of shares has decreased by -0.81% in one year.
| Current Share Class | 126.83M |
| Shares Outstanding | 126.83M |
| Shares Change (YoY) | -0.81% |
| Shares Change (QoQ) | -1.32% |
| Owned by Insiders (%) | 37.58% |
| Owned by Institutions (%) | 39.98% |
| Float | 55.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 72.00 |
| PS Ratio | 1.18 |
| Forward PS | 1.20 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.47 |
| P/FCF Ratio | 131.20 |
| P/OCF Ratio | 38.56 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.81, with an EV/FCF ratio of 109.03.
| EV / Earnings | n/a |
| EV / Sales | 0.94 |
| EV / EBITDA | 11.81 |
| EV / EBIT | 21.16 |
| EV / FCF | 109.03 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.69 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.75 |
| Debt / FCF | 10.37 |
| Interest Coverage | 13.94 |
Financial Efficiency
Return on equity (ROE) is 0.26% and return on invested capital (ROIC) is 3.24%.
| Return on Equity (ROE) | 0.26% |
| Return on Assets (ROA) | 2.81% |
| Return on Invested Capital (ROIC) | 3.24% |
| Return on Capital Employed (ROCE) | 5.12% |
| Revenue Per Employee | $554,710 |
| Profits Per Employee | -$1,078 |
| Employee Count | 869 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 4.25 |
Taxes
| Income Tax | -3.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.11% in the last 52 weeks. The beta is 1.66, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | +52.11% |
| 50-Day Moving Average | 4.23 |
| 200-Day Moving Average | 3.34 |
| Relative Strength Index (RSI) | 44.27 |
| Average Volume (20 Days) | 1,340,053 |
Short Selling Information
The latest short interest is 8.62 million, so 6.79% of the outstanding shares have been sold short.
| Short Interest | 8.62M |
| Short Previous Month | 8.62M |
| Short % of Shares Out | 6.79% |
| Short % of Float | 15.51% |
| Short Ratio (days to cover) | 2.12 |
Income Statement
In the last 12 months, ORGO had revenue of $482.04 million and -$937,000 in losses. Loss per share was -$0.01.
| Revenue | 482.04M |
| Gross Profit | 366.30M |
| Operating Income | 21.52M |
| Pretax Income | n/a |
| Net Income | -937,000 |
| EBITDA | 38.54M |
| EBIT | 21.52M |
| Loss Per Share | -$0.01 |
Full Income StatementBalance Sheet
The company has $135.88 million in cash and $43.31 million in debt, giving a net cash position of $92.57 million or $0.73 per share.
| Cash & Cash Equivalents | 135.88M |
| Total Debt | 43.31M |
| Net Cash | 92.57M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 385.32M |
| Book Value Per Share | 2.09 |
| Working Capital | 208.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.21 million and capital expenditures -$10.03 million, giving a free cash flow of $4.18 million.
| Operating Cash Flow | 14.21M |
| Capital Expenditures | -10.03M |
| Free Cash Flow | 4.18M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 75.99%, with operating and profit margins of 4.46% and 0.18%.
| Gross Margin | 75.99% |
| Operating Margin | 4.46% |
| Pretax Margin | -0.58% |
| Profit Margin | 0.18% |
| EBITDA Margin | 8.00% |
| EBIT Margin | 4.46% |
| FCF Margin | 0.87% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.81% |
| Shareholder Yield | 0.81% |
| Earnings Yield | -0.17% |
| FCF Yield | 0.76% |
Analyst Forecast
The average price target for ORGO is $5.50, which is 27.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.50 |
| Price Target Difference | 27.32% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 3.65 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.65 |
| Piotroski F-Score | 6 |